Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 11Polycystic Ovary Syndrome 4Prostatic Neoplasms 2Heart Failure 2Cardiotoxicity 2Solid Tumors 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Obesity 1Lung Neoplasms 1Inflammation 1Hyperinsulinism 1Hyperglycemia 1Hereditary Sensory and Autonomic Neuropathies 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Adenocarcinoma of Lung 1

Interventions

Echocardiography 4sacubitril and valsartan sodium hydrate drug combination 3Standard of Care 3Nutrition Assessment 3Exercise 3Electrocardiography 3Carvedilol 3dapagliflozin 2Surveys and Questionnaires 2Spironolactone 2Rituximab 2Lenalidomide 2Ivabradine 2Control Groups 2Blood Specimen Collection 2Atorvastatin 2Adrenergic beta-Antagonists 2ziprasidone 1pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1acalabrutinib 1Zolpidem 1Watchful Waiting 1Warfarin 1Vincristine 1Vecuronium Bromide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × dapagliflozin × Clear all
NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms, Heart Failure, Inflammation

NCT06304857 2024-12-04

PROTECTAA

4th Military Clinical Hospital with Polyclinic, Poland

Phase 3 Recruiting
188 enrolled
Breast

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡